FIELD: medicine.
SUBSTANCE: invention may be used in therapy for differential diagnosis of the alcoholic liver disease (ALD). The technique involves serum analysis to measure serum secretory immunoglobulin A (ssIgA) and total immunoglobulin E (IgE) by enzyme-linked immunosorbent assay, and if the ssIgA concentration is more than 5.47 mg/l and the IgE concentration is more than 25 IU/ml, the alcoholic liver disease is diagnosed; if the ssIgA concentration is 5.47 mg/l or less, and the IgE concentration is 25 IU/ml or less, the non-alcoholic fatty liver disease (NAFLD) is diagnosed.
EFFECT: technique has high-sensitivity and specificity, requires no additional blood sampling procedures necessary for determining the most biochemical values measured in the patients with the suspected ALD, and it also enables differentiating the ALD and the NAFLD.
4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN OF THE EUROPEAN POPULATION DURING SCREENING EXAMINATIONS | 2021 |
|
RU2760092C1 |
METHOD OF EARLY DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2022 |
|
RU2798723C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF ACUTE AND SUBACUTE INFECTIOUS ENDOCARDITIS ACCORDING TO IMMUNE INDICATOR | 2017 |
|
RU2675264C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN MEN | 2020 |
|
RU2753455C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
USE OF CISTUS EXTRACT AS HEPATOPROTECTIVE AGENT FOR THERAPEUTIC TREATMENT OF LIVER DISEASES | 2022 |
|
RU2825318C2 |
METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 |
|
RU2675015C1 |
NALMEFEN, NALTREXONE OR DERIVATIVES THEREOF FOR USE IN TREATING (NON)-ALCOHOLIC STEATOHEPATITIS OR NON-ALCOHOLIC FATTY LIVER DISEASE | 2017 |
|
RU2717677C1 |
METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
Authors
Dates
2014-10-10—Published
2013-09-17—Filed